Rupert Mayershofer
Overview
Explore the profile of Rupert Mayershofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Gharahkhani P, Levine D, Fitzgerald R, Gockel I, Corley D, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jun;
31(9):1735-1745.
PMID: 35709760
Background: Over 20 susceptibility single-nucleotide polymorphisms (SNP) have been identified for esophageal adenocarcinoma (EAC) and its precursor, Barrett esophagus (BE), explaining a small portion of heritability. Methods: Using genetic data...
2.
Dighe S, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, et al.
Carcinogenesis
. 2020 Dec;
42(3):369-377.
PMID: 33300568
Genome-wide association studies (GWAS) of esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), have uncovered significant genetic components of risk, but most heritability remains unexplained. Targeted assessment of genetic...
3.
Schroder J, Schuller V, May A, Gerges C, Anders M, Becker J, et al.
PLoS One
. 2020 Jan;
14(12):e0227072.
PMID: 31891614
Esophageal adenocarcinoma (EA) and its precancerous condition Barrett's esophagus (BE) are multifactorial diseases with rising prevalence rates in Western populations. A recent meta-analysis of genome-wide association studies (GWAS) data identified...
4.
Bohmer A, Hecker J, Schroder J, Gharahkhani P, May A, Gerges C, et al.
Cancer Epidemiol Biomarkers Prev
. 2019 Nov;
29(2):427-433.
PMID: 31748258
Background: Obesity is a major risk factor for esophageal adenocarcinoma (EA) and its precursor Barrett's esophagus (BE). Research suggests that individuals with high genetic risk to obesity have a higher...
5.
Dong J, Gharahkhani P, Chow W, Gammon M, Liu G, Caldas C, et al.
Clin Gastroenterol Hepatol
. 2019 Feb;
17(11):2227-2235.e1.
PMID: 30716477
Background & Aims: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study...
6.
Baltes P, Bota M, Albert J, Philipper M, Horster H, Hagenmuller F, et al.
World J Gastroenterol
. 2018 Aug;
24(31):3556-3566.
PMID: 30131662
Aim: To evaluate the ability of PillCamColon2 to visualize colonic segments missed by incomplete optical colonoscopy (OC) and to assess the diagnostic yield. Methods: This prospective multicentre study included 81...
7.
Gharahkhani P, Fitzgerald R, Vaughan T, Palles C, Gockel I, Tomlinson I, et al.
Lancet Oncol
. 2016 Aug;
17(10):1363-1373.
PMID: 27527254
Background: Oesophageal adenocarcinoma represents one of the fastest rising cancers in high-income countries. Barrett's oesophagus is the premalignant precursor of oesophageal adenocarcinoma. However, only a few patients with Barrett's oesophagus...
8.
Becker J, May A, Gerges C, Anders M, Schmidt C, Veits L, et al.
Cancer Med
. 2016 Jan;
5(5):888-91.
PMID: 26783083
Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) represent two stages within the esophagitis-metaplasia-dysplasia-adenocarcinoma sequence. Previously genetic risk factors have been identified that confer risk to BE and EAC development. However,...
9.
Becker J, May A, Gerges C, Anders M, Veits L, Weise K, et al.
Cancer Med
. 2015 Sep;
4(11):1700-4.
PMID: 26383589
The Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) recently performed a genome-wide association study (GWAS) on esophageal adenocarcinoma (EAC) and Barrett's esophagus. They identified genome-wide significant association for variants at three...
10.
Spada C, Hassan C, Munoz-Navas M, Neuhaus H, Deviere J, Fockens P, et al.
Gastrointest Endosc
. 2011 May;
74(3):581-589.e1.
PMID: 21601200
Background: Colon capsule endoscopy (CCE) represents a noninvasive technology that allows visualization of the colon without requiring sedation and air insufflation. A second-generation colon capsule endoscopy system (PillCam Colon 2)...